QuidelOrtho Corporation QDEL
10.94
0.25
2.34%
as of 25 Sep
- Market cap
- $733.1M
- P/E
- 0.0×
Follow QDEL
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(45.16%) | (46.15%) | (49.95%) | (45.91%) | |
| (18.91%) | (18.56%) | (20.03%) | (17.34%) | ||
ROIC |
(12.96%) | (13.05%) | (13.97%) | (11.35%) | |
Return on Tangible Assets |
(61.37%) | (61.53%) | (69.04%) | (60.89%) | |
Average Days of Receivables |
51.97 | 55.75 | 49.44 | 48.04 | |
Free Cash Flow per Share |
(2.11) | (1.22) | (2.34) | (3.09) | |
Free Cash Flow |
(143.80) | (83.00) | (159.40) | (211.20) | |
Capital Expenditures |
(180.80) | (188.20) | (166.00) | (154.00) | |
Piotroski F-Score |
5.00 | 6.00 | 4.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
0.77% | 2.22% | 0.14% | (1.19%) | |
Accounts Receivable Turnover |
7.97 | 7.81 | 8.23 | 8.53 | |
Accounts Payable Turnover |
6.22 | 5.54 | 6.17 | 6.51 | |
Inventory Turnover |
2.41 | 2.62 | 2.49 | 2.47 | |
Average Days of Payables |
54.37 | 70.04 | 60.77 | 58.27 | |
Days of Inventory on Hand |
156.18 | 144.80 | 152.61 | 152.48 | |
Tax Rate |
0.04 | 0.02 | 0.03 | 0.02 | |
Research and Development Expense of Revenue |
6.91% | 6.82% | 6.70% | 6.76% | |
Selling, General and Administrative Expense of Revenue |
27.24% | 27.33% | 28.55% | 28.80% | |
Share Based Compensation of Revenue |
1.65% | 1.68% | 1.69% | 1.65% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(0.03) | (0.09) | (0.01) | 0.05 | |
Depreciation/Fixed assets |
0.92 | 0.84 | 0.86 | 0.87 | |
Capex/Depreciation |
(0.15) | (0.16) | (0.14) | (0.13) | |
Revenue per Share |
39.92 | 40.27 | 38.96 | 39.15 | |
Operating CF per Share |
0.54 | 1.55 | 0.10 | (0.84) | |
Capex per Share |
(2.66) | (2.78) | (2.43) | (2.25) | |
Capex to Sales |
0.07 | 0.07 | 0.06 | 0.06 | |
Net Profit Margin |
(43.45%) | (41.45%) | (45.57%) | (39.20%) |
Columns are period end dates